<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01007929</url>
  </required_header>
  <id_info>
    <org_study_id>D4260C00010</org_study_id>
    <nct_id>NCT01007929</nct_id>
  </id_info>
  <brief_title>Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects</brief_title>
  <official_title>An Open-Label. Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics Following a Single Oral Dose of 60 mg of [14C] AZD1236 in Healthy Male Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterise the metabolism, excretion and pharmacokinetics
      of a single oral dose of [14C] AZD1236 in healthy male subjects.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Future development of AZD1236 is currently under review by the project team and no new studies
    will be started until this review is completed.
  </why_stopped>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">November 2009</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pharmacokinetic profile. Concentration of AZD1236 in plasma</measure>
    <time_frame>Before and after dosing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Radioactivity</measure>
    <time_frame>Before and after dosing</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events, clinical chemistry, haematology, urinalysis, pulse and blood pressure, ECG and physical examination</measure>
    <time_frame>Before and after dosing</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">4</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>14C-AZD1236</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>14C-AZD1236</intervention_name>
    <description>Oral solution 1mg/mL</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

          -  Non-smokers

        Exclusion Criteria:

          -  Subjects who are exposed to radiation exposure as part of their occupation

          -  Subjects exposed to radiation levels above background of &gt;5 mSv in last year, &gt;10 mSv
             over last 5 years or a cumulative total of &gt; 1 mSv per year of life

          -  A history or presence of conditions known to interfere with the absorption,
             distribution, metabolism or excretion for drugs eg. haematological, gastrointestinal,
             hepatic or renal disease etc
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AstraZeneca CPU Medical Director</last_name>
    <role>Principal Investigator</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Macclesfield</city>
        <state>Cheshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2009</study_first_submitted>
  <study_first_submitted_qc>November 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2009</study_first_posted>
  <last_update_submitted>November 19, 2009</last_update_submitted>
  <last_update_submitted_qc>November 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2009</last_update_posted>
  <responsible_party>
    <name_title>MSD</name_title>
    <organization>AstraZeneca</organization>
  </responsible_party>
  <keyword>ADME</keyword>
  <keyword>safety</keyword>
  <keyword>oral solution</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

